Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-17-000675

← back to feed
Filed
Feb 10, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Feb 10, 2017 7.56M sh
Shares Diluted Q2 2017 · Dec 31, 2016 7.52M sh
Shares Diluted Q2 2017 · Dec 31, 2016 7.33M sh
Shares Diluted Q2 2017 · Dec 31, 2015 5.57M sh
Shares Diluted Q2 2017 · Dec 31, 2015 5.24M sh
Stockholders Equity Q2 2017 · Dec 31, 2016 −$3.46M
Stockholders Equity Q2 2017 · Jun 30, 2016 −$3.04M
Current Liabilities Q2 2017 · Dec 31, 2016 $1.33M
Current Liabilities Q2 2017 · Jun 30, 2016 $1.09M
Total Liabilities Q2 2017 · Dec 31, 2016 $4.05M
Total Liabilities Q2 2017 · Jun 30, 2016 $3.54M
Current Assets Q2 2017 · Dec 31, 2016 $591.21K
Current Assets Q2 2017 · Jun 30, 2016 $495.94K
Total Assets Q2 2017 · Dec 31, 2016 $591.21K
Total Assets Q2 2017 · Jun 30, 2016 $495.94K
Operating Income Q2 2017 · Dec 31, 2016 −$10.69M
Operating Income Q2 2017 · Dec 31, 2016 −$1.02M
Operating Income Q2 2017 · Dec 31, 2015 −$518.39K
Operating Income Q2 2017 · Dec 31, 2015 −$1.07M
Operating Cash Flow Q2 2017 · Dec 31, 2015 −$162.34K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $7.64K
Cash And Equivalents Q2 2017 · Jun 30, 2015 $486
Sga Expense restated Q2 2017 · Dec 31, 2015 $385.41K
Sga Expense Q2 2017 · Dec 31, 2015 $726.45K
Net Income Q2 2017 · Dec 31, 2015 −$518.39K
Net Income Q2 2017 · Dec 31, 2015 −$1.07M